David A Ford Selected Research

2-chlorohexadecanal

7/2008	2-Chlorohexadecanal and 2-chlorohexadecanoic acid induce COX-2 expression in human coronary artery endothelial cells.
6/2006	Metabolism of myeloperoxidase-derived 2-chlorohexadecanal.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David A Ford Research Topics

Disease

14	Inflammation (Inflammations) 07/2020 - 02/2002
12	Atherosclerosis 01/2019 - 09/2003
7	Sepsis (Septicemia) 01/2022 - 12/2017
6	Neoplasms (Cancer) 01/2021 - 01/2018
5	Obesity 12/2021 - 01/2013
4	Body Weight (Weight, Body) 12/2021 - 04/2015
4	Lung Injury 01/2021 - 01/2020
4	Atherosclerotic Plaque (Atheroma) 08/2013 - 12/2003
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 12/2017
3	Insulin Resistance 12/2021 - 06/2015
3	Acute Lung Injury 05/2021 - 01/2020
3	Melanoma (Melanoma, Malignant) 01/2021 - 01/2019
3	Breast Neoplasms (Breast Cancer) 01/2021 - 11/2018
3	Wounds and Injuries (Trauma) 11/2020 - 01/2017
3	Cardiovascular Diseases (Cardiovascular Disease) 09/2014 - 09/2009
2	Infections 01/2022 - 07/2013
2	Pre-Eclampsia (Preeclampsia) 05/2021 - 01/2017
2	Hemolysis 01/2021 - 01/2020
2	Mouth Neoplasms (Oral Cancer) 11/2019 - 10/2019
2	Ischemia 01/2019 - 01/2019
2	Gallstones (Gallstone) 06/2017 - 04/2015
2	Pulmonary Alveolar Proteinosis 01/2017 - 12/2014
2	Coronary Artery Disease (Coronary Atherosclerosis) 10/2013 - 12/2003
2	Coronary Disease (Coronary Heart Disease) 08/2013 - 01/2012
2	Myocardial Infarction 01/2012 - 06/2005
2	Infarction (Infarctions) 01/2012 - 06/2005
1	COVID-19 01/2022
1	Respiratory Acidosis 01/2021
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2021
1	Acute Chest Syndrome 01/2021
1	Tularemia 07/2020
1	Herpes Zoster 01/2020
1	Pulmonary Edema 01/2020
1	Hemorrhagic Shock 01/2019
1	Heart Failure 01/2019
1	Progeria (Hutchinson Gilford Syndrome) 01/2019

Drug/Important Bio-Agent (IBA)

19	LipidsIBA 01/2022 - 09/2009
12	Peroxidase (Myeloperoxidase)IBA 12/2021 - 09/2003
10	CholesterolIBA 12/2021 - 05/2008
8	PlasmalogensIBA 01/2022 - 02/2002
7	Phospholipids (Phosphatides)FDA LinkGeneric 01/2022 - 10/2002
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2009
4	HalogensIBA 05/2021 - 01/2017
4	Proteins (Proteins, Gene)FDA Link 11/2020 - 10/2019
4	AcidsIBA 11/2020 - 09/2014
4	AldehydesIBA 01/2020 - 02/2002
3	Insulin (Novolin)FDA Link 12/2021 - 10/2014
3	EnzymesIBA 01/2021 - 01/2012
3	BromineIBA 11/2020 - 01/2017
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 10/2014
3	Triglycerides (Triacylglycerol)IBA 03/2016 - 10/2013
2	CytokinesIBA 01/2022 - 01/2020
2	Tyrosine (L-Tyrosine)FDA Link 05/2021 - 01/2017
2	Heme (Haem)IBA 01/2021 - 01/2020
2	oxidized low density lipoproteinIBA 01/2021 - 09/2003
2	ChlorineIBA 01/2021 - 01/2016
2	HemopexinIBA 01/2021 - 01/2020
2	Lipoproteins (Lipoprotein)IBA 01/2021 - 08/2013
2	Messenger RNA (mRNA)IBA 10/2019 - 10/2013
2	CarbohydratesIBA 03/2016 - 06/2015
2	ApolipoproteinsIBA 04/2015 - 10/2013
2	CalciumIBA 09/2014 - 07/2013
2	Phosphotransferases (Kinase)IBA 11/2013 - 08/2013
2	Phospholipases (Phospholipase)IBA 07/2013 - 01/2012
2	2-chlorohexadecanalIBA 07/2008 - 06/2006
1	K-18 conjugate (K18)IBA 01/2022
1	1,2-Dipalmitoylphosphatidylcholine (Dipalmitoylphosphatidylcholine)IBA 01/2022
1	phosphatidal ethanolaminesIBA 12/2021
1	FructoseIBA 12/2021
1	Choline (Choline Chloride)IBA 12/2021
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 05/2021
1	Stearic AcidsIBA 01/2021
1	Heme Oxygenase-1IBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Group IV Phospholipases A2IBA 01/2021
1	5-hydroxy-6,8,11,14-eicosatetraenoic acidIBA 07/2020
1	VaccinesIBA 07/2020
1	Biological ProductsIBA 07/2020
1	Lipoxygenase (Lipoxygenase-1)IBA 07/2020
1	HydrazinesIBA 01/2020
1	N-acetyllysyltyrosylcysteine amideIBA 01/2020
1	Mast Cell StabilizersIBA 01/2020
1	4-Aminobenzoic Acid (4 Aminobenzoic Acid)IBA 01/2020
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2020
1	SpectrinIBA 01/2020
1	Cadherins (E-Cadherin)IBA 01/2020
1	ChemokinesIBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	Epithelial Sodium ChannelsIBA 01/2020
1	Pyruvic Acid (Pyruvate)IBA 10/2019
1	CarcinogensIBA 10/2019
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2019
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2019
1	CalpainIBA 01/2019

Therapy/Procedure

8	Therapeutics 01/2021 - 06/2017
3	Immunotherapy 01/2021 - 01/2019
3	bitter melon extract 11/2019 - 11/2018
2	Ligation 01/2020 - 01/2012
1	Intramuscular Injections 01/2020
1	Punctures 01/2020